GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Cyclically Adjusted PS Ratio

Daito Pharmaceutical Co (TSE:4577) Cyclically Adjusted PS Ratio : 0.72 (As of Jun. 08, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-08), Daito Pharmaceutical Co's current share price is 円2229.00. Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 was 円3,081.84. Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 0.72.

The historical rank and industry rank for Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4577' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.6   Med: 0.92   Max: 1.48
Current: 0.72

During the past years, Daito Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 1.48. The lowest was 0.60. And the median was 0.92.

TSE:4577's Cyclically Adjusted PS Ratio is ranked better than
79.41% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs TSE:4577: 0.72

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Daito Pharmaceutical Co's adjusted revenue per share data for the three months ended in Feb. 2024 was 円672.316. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円3,081.84 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Daito Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.44 1.06 0.82 0.70

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.70 0.75 0.63 0.67

Competitive Comparison of Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Daito Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2229.00/3081.84
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, Daito Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Feb. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=672.316/106.9000*106.9000
=672.316

Current CPI (Feb. 2024) = 106.9000.

Daito Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201405 762.584 98.100 830.991
201408 591.275 98.300 643.004
201411 672.846 97.900 734.701
201502 578.383 97.600 633.495
201505 683.626 98.700 740.422
201508 634.488 98.400 689.296
201511 696.272 98.100 758.731
201602 631.190 97.800 689.920
201605 677.146 98.200 737.138
201608 661.923 97.900 722.774
201611 734.436 98.600 796.260
201702 631.986 98.100 688.678
201705 730.193 98.600 791.660
201708 703.425 98.500 763.413
201711 782.687 99.100 844.291
201802 667.082 99.500 716.694
201805 744.272 99.300 801.235
201808 707.547 99.800 757.884
201811 756.109 100.000 808.281
201902 745.093 99.700 798.901
201905 779.683 100.000 833.481
201908 847.074 100.000 905.522
201911 832.905 100.500 885.946
202002 785.160 100.300 836.826
202005 732.149 100.100 781.885
202008 924.754 100.100 987.574
202011 817.566 99.500 878.370
202102 782.355 99.800 838.014
202105 720.601 99.400 774.972
202108 778.706 99.700 834.942
202111 704.927 100.100 752.814
202202 719.881 100.700 764.203
202205 628.682 101.800 660.178
202208 760.356 102.700 791.451
202211 714.484 103.900 735.114
202302 708.916 104.000 728.684
202305 666.266 105.100 677.677
202308 770.662 105.900 777.939
202311 752.713 106.900 752.713
202402 672.316 106.900 672.316

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Daito Pharmaceutical Co  (TSE:4577) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Daito Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co (TSE:4577) Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines